DE602006021395D1 - Screening-verfahren - Google Patents

Screening-verfahren

Info

Publication number
DE602006021395D1
DE602006021395D1 DE602006021395T DE602006021395T DE602006021395D1 DE 602006021395 D1 DE602006021395 D1 DE 602006021395D1 DE 602006021395 T DE602006021395 T DE 602006021395T DE 602006021395 T DE602006021395 T DE 602006021395T DE 602006021395 D1 DE602006021395 D1 DE 602006021395D1
Authority
DE
Germany
Prior art keywords
peptides
ionized
species
screening process
defined series
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006021395T
Other languages
English (en)
Inventor
Charles Turner
Raymond Neil Dalton
Yvonne Anne Daniel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guys and St Thomas NHS Foundation Trust
Kings College London
Original Assignee
Guys and St Thomas NHS Foundation Trust
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34307799&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006021395(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Guys and St Thomas NHS Foundation Trust, Kings College London filed Critical Guys and St Thomas NHS Foundation Trust
Publication of DE602006021395D1 publication Critical patent/DE602006021395D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/976Trypsin; Chymotrypsin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE602006021395T 2005-02-01 2006-02-01 Screening-verfahren Active DE602006021395D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0502068.0A GB0502068D0 (en) 2005-02-01 2005-02-01 Screening method
PCT/GB2006/000328 WO2006082389A1 (en) 2005-02-01 2006-02-01 Screening method

Publications (1)

Publication Number Publication Date
DE602006021395D1 true DE602006021395D1 (de) 2011-06-01

Family

ID=34307799

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006021395T Active DE602006021395D1 (de) 2005-02-01 2006-02-01 Screening-verfahren

Country Status (11)

Country Link
US (2) US8658396B2 (de)
EP (1) EP1844338B1 (de)
JP (1) JP5279273B2 (de)
CN (1) CN101128739A (de)
AT (1) ATE506616T1 (de)
AU (1) AU2006210707B2 (de)
CA (1) CA2596010C (de)
DE (1) DE602006021395D1 (de)
ES (1) ES2365041T3 (de)
GB (1) GB0502068D0 (de)
WO (1) WO2006082389A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2729491C2 (ru) * 2015-03-27 2020-08-07 Нейро-Био Лтд Антитело, которое распознает пептид т14 асне

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2625781C (en) * 2005-10-13 2014-09-02 Applera Corporation Methods for the development of a biomolecule assay
EP2017622A1 (de) 2007-07-19 2009-01-21 DKFZ Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen Rechts Verfahren zur Bestimmung der Konzentration eines Moleküls
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
US8603828B2 (en) * 2009-11-18 2013-12-10 Bio-Rad Laboratories, Inc. Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
CN102401813B (zh) * 2010-09-17 2013-12-18 国立交通大学 变异血红素的快速分析方法
US9594074B2 (en) * 2012-12-26 2017-03-14 Quest Diagnostics Investments Incorporated C peptide detection by mass spectrometry
CA2927752A1 (en) 2013-10-18 2015-04-23 The Regents Of The University Of Michigan Systems and methods for determining a treatment course of action
GB201415367D0 (en) * 2014-08-29 2014-10-15 Iles Raymond K And Docherty Suzanne M E And Abban Thomas And Naase Mahmoud And Iles Jason K Methods for detecting abnormalities in haemoglobin
GB201417387D0 (en) * 2014-10-01 2014-11-12 Micromass Ltd Haemoglobin variant analysis using pseudo MS/MS/MS via atmospheric pressures elctron capture dissociation ("AP-ECD") and collision induced dissociation("CID")
WO2017022562A1 (ja) * 2015-08-03 2017-02-09 株式会社島津製作所 タンパク質変異体の並行的定量方法
EP3521828A1 (de) * 2018-01-31 2019-08-07 Centogene AG Verfahren zur diagnose eines hereditären angioödems
CN112689762B (zh) * 2018-06-01 2024-08-23 美国控股实验室公司 用于lc-ms/ms蛋白质组学基因分型的方法和系统
WO2020072996A1 (en) * 2018-10-05 2020-04-09 Seattle Children's Hospital (D/B/A Seattle Children's Research Institute) Newborn screening for primary immunodeficiencies, cystinosis, and wilson disease
BE1027232B1 (fr) * 2019-08-28 2020-11-20 Zentech S A Procédé de détection d'au moins un variant de protéine et/ou d'au moins un peptide propre aux chaînes alpha et/ou bêta et/ou delta d'hémoglobine
CN111638261B (zh) * 2020-04-17 2023-04-07 融智生物科技(青岛)有限公司 一种计算设备、存储介质和地中海贫血筛查装置及系统
WO2023238005A1 (en) * 2022-06-06 2023-12-14 Neuberg Anand Academy Of Laborato Ry Medicine Private Limited A method for screening hemoglobinopathies by globin chain analysis using electrospray tandem quadrupole mass spectrometry.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2255122C (en) * 1998-12-04 2007-10-09 Mds Inc. Improvements in ms/ms methods for a quadrupole/time of flight tandem mass spectrometer
US8669116B2 (en) 2002-03-11 2014-03-11 President And Fellows Of Harvard College Detection and quantification of modified proteins
WO2003089937A2 (en) 2002-04-15 2003-10-30 Thermo Finnigan, Llc Quantitation of biological molecules
WO2004019043A2 (en) * 2002-08-23 2004-03-04 Bayer Healthcare Ag Polypeptide biomarkers for diagnosing alzheimer's disease
GB0308202D0 (en) 2003-04-09 2003-05-14 King S College London A screening method using mass spectrometry
JP4702284B2 (ja) * 2004-03-30 2011-06-15 日本電気株式会社 タンパク質の分析方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2729491C2 (ru) * 2015-03-27 2020-08-07 Нейро-Био Лтд Антитело, которое распознает пептид т14 асне

Also Published As

Publication number Publication date
EP1844338A1 (de) 2007-10-17
JP2008529027A (ja) 2008-07-31
AU2006210707A1 (en) 2006-08-10
CA2596010C (en) 2014-09-30
GB0502068D0 (en) 2005-03-09
US9347084B2 (en) 2016-05-24
AU2006210707B2 (en) 2011-10-13
US8658396B2 (en) 2014-02-25
ES2365041T3 (es) 2011-09-21
JP5279273B2 (ja) 2013-09-04
WO2006082389A1 (en) 2006-08-10
CA2596010A1 (en) 2006-08-10
ATE506616T1 (de) 2011-05-15
US20080280345A1 (en) 2008-11-13
US20140212906A1 (en) 2014-07-31
CN101128739A (zh) 2008-02-20
EP1844338B1 (de) 2011-04-20

Similar Documents

Publication Publication Date Title
DE602006021395D1 (de) Screening-verfahren
MX337569B (es) Ligandos de proteina prion y metodos de uso.
ATE495447T1 (de) Peptidantikörperdepletion und anwendung zur probenvorbereitung für massenspektrometrie
SG153699A1 (en) Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
WO2007041520A3 (en) Methods for direct protein identification by maldi
ATE417273T1 (de) Proteinphosphorylierung bei grosszellig- anaplastischem lymphom
ATE529752T1 (de) Antikörperquantifizierung
AU2003224674A8 (en) Compounds and methods for analyzing the proteome
IL176479A0 (en) Methods and compositions for identifying rna-binding proteins
ATE460666T1 (de) Verfahren zur bestimmung der aminosäurensequenz von peptiden
EP1730276B8 (de) Verfahren, chip, vorrichtung und system zur extraktion biologischer materialien
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
MX2023000877A (es) Metodos para la caracterizacion de anticuerpos de tipo del medio hacia abajo.
DK1844333T3 (da) Fremgangsmåde til eftervisning og fjernelse af endotoxiner
ATE288589T1 (de) Verfahren zur analyse von proteinen
UA112515C2 (uk) Спосіб виявлення присутності двох або більше білків, що становлять інтерес, в зразках рослинного походження
WO2005091199A3 (en) A method for identifying unknown proteins by a two-dimensional step and the use of markers
DE50308017D1 (de) Verfahren zur extraktion von proteinen
WO2007095378A3 (en) Mass tagging for quantitative analysis of biomolecules using 13c labeled phenylisocyanate
EP1748297B8 (de) Massenspektrometrie-Analyse von natürlich vorkommenden Peptiden und kleinen Proteinen
Kuyama et al. Enriching C-terminal peptide from endopeptidase ArgC digest for protein C-terminal analysis
EP1874799A4 (de) Hochauflösende verfahren und ausfällungsreagentien zur isolierung von proteinen aus proteinhaltigem material
DE602004017286D1 (en) Screening test
DE60319726D1 (de) Verfahren und kit zum nachweis von antigenen
WO2007100748A3 (en) Protein separation and analysis